From: Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
Generic name
Trade name
Dose (daily)
Number of cases of monotherapy
Sitagliptin
Jauvia®, Glactive®
50 mg
879
Vildagliptin
Equa®
100 mg
253
Teneligliptin
Tenelia®
20 mg
260
Alogliptin
Nesina®
25 mg
237
Linagliptin
Trasenta®
5 mg
180